John Klein, Cambridge Therapeutics Tumblr Blog

Serving as chairman of Cambridge Therapeutics, John Klein is a respected presence in the Alpine, New Jersey, entrepreneurial community. In his role as chairman, he delivers novel drug development and physician dispensing solutions. Drawing on his leadership experience in Alpine, NJ, with Cambridge Therapeutics, John Klein is working to launch Bilogix, which offers consulting services using the enterprise performance management (EPM) process. The NJ firm’s EPM approach is one that employs a structured methodology in defining corporate areas in need of improvement and generating analytically defined solutions. A foundational aspect of measuring enterprise needs is continuous monitoring within a six sigma framework. Key performance indicators (KPI) for the company are defined and employed within a predictive planning process, which includes cost analysis, financial modeling, and a close look at emerging market dynamics. By emphasizing accurate business reporting, resources can be directed in tactical situations that generate revenue and boost productivity, both within specific divisions and across the company as a whole.

John Klein is the founder of Cambridge Therapeutics, a health care and pharmaceutical firm located in Alpine, NJ, where he serves as chairman. For nearly five years, John Klein has balanced his responsibilities at Cambridge Therapeutics with an executive leadership role at Bilogix. Bilogix is a provider of enterprise performance management (EPM) support and related services. EPM processes are run through Cognizant Business Consulting (CBC), the consulting arm of Enterprise Analytics (EA). Cognizant’s carefully developed EPM services are rooted in data-driven strategic initiatives designed to resolve performance management issues. Common elements of EPM reporting include management dashboards and scorecards, which help equate business tactics with key performance indicators (KPIs), and a customized KPI index tracker. Cognizant’s services address the complete spectrum of EPM solutions, from strategy and metrics visualization to integrated performance management systems. Furthermore, the Cognizant EPM methodology includes a quick start model for businesses seeking immediate scorecard development, which is made possible through KPI reserves and related lag and lead indicator prediction tools. More information about Cognizant EPM solutions and services can be found at www.cognizant.com.

The chairman of Cambridge Therapeutics in Alpine, NJ, John Klein possesses more than two decades of experience in pharmaceutical manufacturing. Aside from his role guiding Cambridge Therapeutics, Alpine resident John Klein recently founded Bilogix. A firm that offers enterprise performance management (EPM) consulting services, Bilogix fills a growing need for businesses that need new strategies to thrive in the 21st-century marketplace. Bilogix employs experienced EPM consultants who help executives conduct a strategic analysis of their Business Intelligence (BI) solutions and identify ways to enhance overall operational efficiency to maintain their competitive edge. An EPM review includes a comprehensive evaluation of business resources and performance. For instance, EPM consultants review the company’s existing resources and how they are deployed. As part of the process, the consultant may suggest that the company revamp the way it deploys its business resources, including the company’s workforce, facilities, and technical infrastructure. The EPM process also includes a full review of the company’s finances and expenditures, with an eye to how much value the company’s expenses generate for the business. This return-on-investment (ROI) data helps management find more efficient ways to deploy resources to boost performance and increase profits.

John Klein is an experienced business leader who serves as the chairman of the New Jersey-based firm Cambridge Therapeutics. For his professional accomplishments and contributions to the welfare of the United States, John Klein received the prestigious Ellis Island Medal of Honor in 1997. The Ellis Island Medal of Honor is awarded to a small group of native-born or naturalized US citizens who have made significant achievements in their professional field and strongly demonstrated the American spirit through diversity, patriotism, tolerance, and brotherhood. Listed here are three of the most iconic and well-known Ellis Island Medal honorees. Rosa Parks Famed civil-rights activist Rosa Parks received her medal in 1986. She first gained the public’s notice in 1955 after she refused to take a seat at the back of a bus in Montgomery, Alabama, and in so doing, made a stand for the rights of African Americans across the country. Parks remained a political activist for the rest of her life and became an icon of the Civil Rights movement in America. Elie Wiesel A Holocaust survivor and world-famous human-rights advocate, Elie Wiesel is the best-selling author of Night, a memoir of his own experiences as a prisoner in the Nazi death camps Auschwitz and Buchenwald. After emigrating to the United States, Wiesel became a professor and nonprofit founder alongside his wife, Marion. He won the Nobel Peace Prize in 1986 and the Ellis Island Medal in 1992. Muhammad Ali One of the most famous professional boxers of all time, Muhammad Ali earned his Ellis Island Medal in 1986 alongside Rosa Parks. He won the heavyweight world-championship title three separate times and was the first to ever do so. After he retired from boxing, he became a dedicated philanthropist. In 2005, he also earned the Presidential Medal of Freedom.

John Klein leads Cambridge Therapeutics in Teaneck, New Jersey, as the pharmaceutical manufacturing company’s chairman. At Cambridge Therapeutics, John Klein and his team specifically work to translate innovations in the design of medical devices and packaging into products that help patients stay compliant with their medication routines. Cambridge Therapeutics’ pioneering products include its Compliance PACs, a prescription package that makes it simpler for patients to know when and how to take their medications. These calendarized dosage packs enable a patient or caregiver to see which medications to take, on which days and at which times. Users can also note at a single glance which prescriptions need to be refilled at the pharmacy. The Compliance PAC prescriptions do not arrive in the familiar brown medicine bottle. Instead, they are sealed into flat boxes whose long, flat sides are color-coded for the type of medication inside. The names of the medications - and their correct dosages - are additionally clearly written in large typeface on the box, and each box contains a blister card. And, to keep confusion to a minimum, each medication features pills with consistent shapes, sizing, and coloration. The Compliance PACs also feature child-resistant designs with lock-release buttons for extra safety.

John Klein serves as the chairman of Cambridge Therapeutics, the New Jersey-based pharmaceutical and medical-device manufacturing firm he established in 2011. Before founding Cambridge Therapeutics, he served in leadership positions with Zenith Laboratories and Ivax Pharmaceutical. John Klein is also a committed philanthropist and a recipient of the Ellis Island Medal of Honor. The medal is presented annually to accomplished individuals in business, government, science, the arts, and popular culture who exemplify the values that define the American immigrant experience and the history of American striving to create a better and more just society. The values championed through the medal ceremony continue to bind new immigrants and native-born Americans together: tolerance, diversity, courage, compassion, and public service. The United States Congress has acknowledged the prestigious nature of these awards by memorializing the recipients in the Congressional Record. The Congressional Record for September 16, 1997, lists John Klein among that year’s Ellis Island Medal of Honor recipients, alongside other notable individuals. Over the years, the medal has been awarded to American presidents, moral leaders such as Elie Wiesel and Coretta Scott King, and celebrities such as Michael Douglas, Bob Hope, and Frank Sinatra. The Ellis Island Honors Society selects each year’s recipients. The society’s annual gala celebrates medal recipients’ history of giving back to their communities, and raises funds to maintain Ellis Island as a historic monument to the generations of immigrants who passed through it as their portal to a new and better life.

Based in New Jersey, John Klein serves as the chairman of pharmaceutical manufacturer Cambridge Therapeutics. His decades of work in the industry includes executive positions with some of the field’s major brands. At Cambridge Therapeutics, John Klein and his team focus on offering a variety of high-quality medical products, notably with user-friendly packaging that encourages patient compliance. Non-adherence - when patients neglect or refuse to take their medications correctly or at all - is responsible for an estimated 10 million admissions to hospitals annually and close to 80 million doctor visits on an outpatient basis. These statistics add up to an additional yearly cost to the American healthcare system of some $300 billion. More serious is the fact that well over 100,000 people a year die due to skipping doses, discontinuing their medications on their own, and other types of non-adherence. Cambridge Therapeutics’ innovative packaging is the result of its professional team’s focus on designing safe, child-resistant, yet frustration-free packaging that contributes to greater patient adherence to a doctor’s prescription. The patented packaging is easy for an adult to open, and its calendarized labeling make remembering required dosages far simpler. And when in doubt, patients and their caregivers will find it easy to refer to the packaging to see what each medication looks like, when the last dosage was administered, how many doses remain, and when a refill will be necessary. Studies have shown that such careful package design can have significant positive impact on a patient‘s adherence and long-term well-being.

At New Jersey-based Cambridge Therapeutics, Chairman John Klein leads a team dedicated to providing innovations in product packaging and other delivery systems, as well as in combination drug modalities. At Cambridge Therapeutics, John Klein draws on decades of pharmaceutical-industry experience that includes work with major corporate brands and a role as chairman of the Worldwide Generics Pharmaceutical Industry Association. In this latter position, he gained extensive experience in working with federal regulatory bodies. The history of federal regulation of prescription drugs in the United States is relatively new, coming into being at around the turn of the 20th century, along with numerous other regulations designed to promote public health and safety. One of the landmark pieces of early legislation was the 1906 Pure Food and Drug Act, supported by President Theodore Roosevelt. Roosevelt was known as a champion of regulation of the meatpacking and pharmaceutical industries in the interests of consumer protection. In the summer of 1906, as the bill that would become the law was the subject of vociferous debate in the House of Representatives, Illinois Congressman James Mann delivered a dramatic speech describing how the lack of regulation led to the public being offered alcoholic beverages distilled using chemicals and fruit whose coloration had been altered with toxic dyes. Congress passed the bill, and Roosevelt signed it into law. After a revision in the 1938 Food, Drug, and Cosmetic Act, and subsequent amendments, the major regulations contained in the original legislation remain in place, overseen by the Food and Drug Administration.

The chairman of Cambridge Therapeutics, John Klein possesses more than 30 years of experience as an executive in the health care and pharmaceutical industries. In addition to his work with Cambridge Therapeutics, John Klein serves as a trustee with Hackensack Meridian Health Hospitals. Jersey Shore University Medical Center, which is part of the Hackensack Meridian Health network, recently opened the doors to HOPE Tower, a new $265 million outpatient care facility spanning 300,000 square feet. Located on the medical center’s campus in Neptune, HOPE Tower is known for being adorned with unique landscaping, known as the LiveWall Outdoor Living Wall System. The two living garden walls on the building’s exterior provide more than 500 square feet of green space to the outpatient facility, offering a pleasant aesthetic that is meant to convey a welcoming, accessible, and healthy atmosphere to patients. Each wall measures nearly 23 feet wide and over 11 feet high. The facility also features a garden courtyard with a green roof.

As the chairman of Cambridge Therapeutics in Teaneck, New Jersey, John Klein leverages his extensive experience in the pharmaceutical industry to oversee the company. Under John Klein’s leadership, Cambridge Therapeutics strives to expand the availability of combination drug therapies. Widely regarded as one of the best ways to help prevent disease progression and reduce mortality rates associated with cardiovascular disease, combination drug therapy involves administering two or more pharmacologic agents to a patient to manage an illness or condition. In addition, combination drug therapies have demonstrated effectiveness in treating conditions such as rheumatoid arthritis, Alzheimer’s disease, HIV, diabetes mellitus, and neurological and pulmonary disorders. Pharmacists play a critical role in confirming that a prescribed combination drug therapy is safe for a patient. By reviewing all of a patient’s medications and dosages, pharmacists can identify potential drug interactions or contraindications. Studies have shown that patients tend to adhere to medication regimens better when they are simple, so fixed-dose combination formulations of combined drug therapies are recommended, when appropriate.